Search for: "Purdue Pharma Inc." Results 21 - 40 of 152
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Feb 2013, 4:43 pm by Mandour & Associates
Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug. [read post]
20 Oct 2019, 5:58 am by Fred Abrams
Banela Corporation allegedly owns all the Class A shares of Purdue Pharma, Inc. [read post]
28 Oct 2007, 9:50 pm
Purdue Pharma Products LP et al. v. [read post]
13 May 2007, 5:18 pm
Purdue Pharma Products LP et. al. v. [read post]
28 Oct 2011, 4:30 am
Editors’ Note: For an outstanding article on CAFA jurisdiction and parens patriae, see “Removal of Attorney General Actions Under the Class Action Fairness Act of 2005,” BNA, Inc. [read post]
30 Jan 2019, 5:06 am by Sara E. Teller
Besides Purdue Pharma LP, the list of defendants named in NYC’s suit includes long-time opioid manufacturers Allergan Plc, Endo International Plc, Johnson & Johnson, and Teva Pharmaceutical Industries Ltd., and distributors AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp. [read post]
26 Sep 2017, 12:46 pm by Associated Press
About a dozen pharmaceutical companies, including Purdue Pharma L.P., Janssen Pharmaceuticals Inc. and Allergan PLC, filed a brief Friday saying they’ve complied with the U.S. [read post]
6 Sep 2015, 8:26 am by Green and Associates
The Purdue Frederick Company, Inc., Purdue and its top executives pleaded guilty to charges that it misled doctors and patients about the addictive properties of OxyContin and misbranded the product as "abuse resistant. [read post]
28 Oct 2011, 4:30 am
Editors’ Note: For an outstanding article on CAFA jurisdiction and parens patriae, see “Removal of Attorney General Actions Under the Class Action Fairness Act of 2005,” BNA, Inc. [read post]
23 Apr 2022, 8:48 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc.; Stephen Byrn of Purdue University and Improved Pharma; Steven Zeman of Grünecker Patent Attorneys and Attorneys at Law; and Eyal Barash of Barash Law, LLC will focus on questions related to obviousness and inventive step, enablement and written description sufficiency, and scientific aspects of pharmaceutical salts, and address issues related to litigation of patents directed to such salts from both a legal and expert witness point of… [read post]
15 Jul 2014, 7:10 am by Docket Navigator
Purdue Pharma LP et al, 3-13-cv-00571 (NJD July 9, 2014, Order) (Bongiovanni, M.J.) [read post]
18 Aug 2010, 12:19 am by Kelly
and industrial applicability on 7 October: Eli Lilly & Co v Human Genome Sciences Inc (IPKat) Nuvigil (Armodafinil) – US: Cephalon and Mylan Pharmaceuticals agree to drop two patents from Nuvigil patent suit (Patent Docs) OxyContin (Oxycodone) – Patent infringement complaint filed following a Paragraph IV certification: Purdue Pharma L.P. et al. v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Ryzolt (Tramadol) – US: Patent infringement complaint filed following a Paragraph IV certification: Purdue Pharma Products LP et al. v. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/21: Purdue Pharma Products LP and Napp Pharmaceutical Group Ltd. v. [read post]